|
Munárriz D., Rodríguez-Lobato L.G., López-Corral L., Arnaldos-Pérez C., Cabañas V., López-Muñoz N., Oliver-Caldés A., Ponce J.C., Reguera J.L., Martín A.Á., Martínez-Cibrián N., Tovar N., Delgado J., Guillen E., Varea S., Rodríguez-Otero P., Urbano-Ispizua Á., Moraleda J.M., Martínez-López J., Mateos M.V., De la Calle V.G., González-Navarro E.A., Fernández de Larrea C. Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h. Frontiers in Immunology. 2025. 16. 10.3389/fimmu.2025.1654096
AÑO: 2025; IF: 7.0
|
|
Salinas MD, Martinez CM, Roca FJ, Garcia-Bernal D, Martinez-Morga M, Rodriguez-Madoz JR, Prosper F, Zapata AG, Moraleda JM, Martinez S, Valdor R. Chaperone-mediated autophagy sustains pericyte stemness necessary for brain tissue homeostasis. J Adv Res. 2025 Apr 24:S2090-1232(25)00259-0. doi: 10.1016/j.jare.2025.04.015. Online ahead of print. PubMed PMID: 40286844.
AÑO: 2025; IF: 17.1
|
|
Richardson E, Mo CC, Calabretta E, Corrado F, Kocoglu MH, Baron RM, Connors JM, Iacobelli M, Wei LJ, Benjamin EJ, Rapoport AP, Diaz-Ricart M, Martinez-Mellado AJ, Carlo-Stella C, Richardson PG, Moraleda JM. Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19. Biomolecules. 2025 Jul 14;15(7):1004. doi: 10.3390/biom15071004. PubMed PMID: 40723876; PubMed Central PMCID: PMC12292847.
AÑO: 2025; IF: 5.6
|
|
Zugasti I., Tormo-Ratera M., Oliver-Caldés A., Soler-Perromat J.C., González-Calle V., Moreno D.F., Cabañas V., López-Muñoz N., Bartolomé-Solanas Á., Español-Rego M., Reguera-Ortega J.L., Rosiñol L., López-Corral L., Tovar N., Rodríguez-Lobato L.G., Alvarez Perez R.M., Varea S., Olesti E., Gomez-Grande A., Frutos L., Tamayo P., Juan M., Moraleda J.M., Urbano-Ispizua Á., González-Navarro E.A., Martínez-López J., Mateos M.V., Tomás X., Setoain X., Fernández de Larrea C. Clinical impact of [<sup>18</sup>F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma. Blood Advances. 11 February 2025. 9:571-582. 10.1182/bloodadvances.2024014360
AÑO: 2025; IF: 7.7
|
|
Rodríguez-Fortúnez, P; Martínez-Mellado, AJ; Jara-Rubio, R; Castro-Rebollo, P; Carrillo-Alcaraz, A; Rodríguez-Jiménez, C; Pareja, A; Kiwitt-Cárdenas, J; Torres, A; Moraleda, JM. Safety of defibrotide in the prevention and treatment of acute respiratory distress syndrome in patients with COVID-19. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135:25-26.
AÑO: 2024; IF: 3.3
|